SCHEMBL13075715

SCHEMBL13075715

CCCC(=O)NC(C(N)=O)C(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.45
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MEN1 O00255 1/20 0.41
FAAH O00519 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
CNR1 P21554 5/20 0.40
CNR2 P34972 5/20 0.40
PLA2G2A P14555 1/20 0.38
PLA2G5 P39877 1/20 0.38
DNM1 Q05193 1/20 0.37
PSMB5 P28074 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
PRSS1 P07477 1/20 0.35
CTSG P08311 1/20 0.35
CTRB1 P17538 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4770925 0.89 FAAH (0.52) MEN1FAAHMAPK1KMT2ACNR1
SCHEMBL9664112 0.87 FAAH (0.59) MEN1FAAHMAPK1KMT2APLA2G2A
SCHEMBL18556703 0.87 FAAH (0.59) MEN1FAAHMAPK1KMT2APLA2G2A
SCHEMBL9666920 0.85 FAAH (0.62) MEN1FAAHMAPK1KMT2APLA2G2A
SCHEMBL21587883 0.85 FAAH (0.62) MEN1FAAHMAPK1KMT2APLA2G2A
SCHEMBL19933125 0.85 FAAH (0.62) MEN1FAAHMAPK1KMT2APLA2G2A
SCHEMBL9665948 0.85 FAAH (0.62) MEN1FAAHMAPK1KMT2APLA2G2A
SCHEMBL9666504 0.85 FAAH (0.62) MEN1FAAHMAPK1KMT2APLA2G2A
SCHEMBL9664111 0.85 FAAH (0.62) MEN1FAAHMAPK1KMT2APLA2G2A
SCHEMBL9664778 0.85 FAAH (0.62) MEN1FAAHMAPK1KMT2APLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220169676-A1 INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES WASHINGTON UNIVERSITY (US) 2022-06-02 US disclosed
WO-2010127363-A1 TOPOSIOMERASE INHIBITORS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220169676-A1 INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES HDGF, MMP7, HGF CTSD 190/4885HDAC3 2032/4885HDAC1 934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.